Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma

Condition:   Head and Neck Cancer
Intervention:   Drug: Anti-EGFR monoclonal antibody
Sponsors:   Sinocelltech Ltd.;   Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting

https://ift.tt/2CSmjUh